Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.

Rocio Garcia-CarboneroMiriam Bazan-PeregrinoMarta Gil-MartínRafael ÁlvarezTeresa MacarullaMaria C Riesco-MartinezHelena VerdaguerCarmen Guillén-PonceMartí Farrera-SalRafael MorenoAna Mato-BercianoMaria Victoria MaliandiSilvia Torres-ManjonMarcel CostaNatalia Del PozoJaime Martínez de VillarrealFrancisco X RealNoemí VidalGabriel CapellaRamon AlemanyEmma BlasiCarmen BlascoManel CascallóRamón Salazar

Published in: Journal for immunotherapy of cancer (2022)

NCT02045602.

Keyphrases

open label
clinical trial
high dose
advanced non small cell lung cancer
randomized controlled trial
phase ii study
chemotherapy induced